The metabolic pathway by which ␤-D-galactose is converted to glucose 1-phosphate is known as the Leloir pathway and consists of four enzymes. In most organisms, these enzymes appear to exist as soluble entities in the cytoplasm. In yeast such as Saccharomyces cerevisiae, however, the first and last enzymes of the pathway, galactose mutarotase and UDP-galactose 4-epimerase, are contained within a single polypeptide chain referred to as Gal10p. Here we report the three-dimensional structure of Gal10p in complex with NAD ؉ , UDP-glucose, and ␤-D-galactose determined to 1.85-Å resolution. The enzyme is dimeric with dimensions of ϳ91 Å ؋ 135 Å ؋ 108 Å and assumes an almost V-shaped appearance. The overall architecture of the individual subunits can be described in terms of two separate Nand C-terminal domains connected by a ␤-D-Galactose is converted to the more metabolically useful glucose 1-phosphate by the action of four enzymes that constitute the Leloir pathway as shown in Scheme 1 (reviewed in Ref. 1). Mutations in the genes that encode for three of these enzymes in humans, specifically galactokinase, galactose-1-phosphate uridylyltransferase, and UDP-galactose 4-epimerase, result in the diseased state referred to collectively as galactosemia (2-4). The clinical severity of these disorders varies widely, depending upon the gene affected and the resulting degree of enzyme impairment. Common symptoms include cataract formation, impaired cognitive development, and liver dysfunction among others.
␤-D-Galactose is converted to the more metabolically useful glucose 1-phosphate by the action of four enzymes that constitute the Leloir pathway as shown in Scheme 1 (reviewed in Ref. 1) . Mutations in the genes that encode for three of these enzymes in humans, specifically galactokinase, galactose-1-phosphate uridylyltransferase, and UDP-galactose 4-epimerase, result in the diseased state referred to collectively as galactosemia (2) (3) (4) . The clinical severity of these disorders varies widely, depending upon the gene affected and the resulting degree of enzyme impairment. Common symptoms include cataract formation, impaired cognitive development, and liver dysfunction among others.
In the first step of the Leloir pathway, ␤-D-galactose is converted to ␣-D-galactose by galactose mutarotase. The structures of the mutarotases from both Lactococcus lactis and human have been solved and shown to adopt a distinctive ␤-sandwich motif (5) (6) (7) . From a combined structural and functional analysis of the enzyme from L. lactis, it has been postulated that a conserved glutamate residue serves as the active site base to abstract the sugar C-1 hydroxyl hydrogen and that a conserved histidine functions as the active site acid to protonate the C-5 ring oxygen, thereby leading to ring opening (8) . Subsequent rotation about the C-1-C-2 bond by 180 o followed by abstraction of the proton on the C-5 oxygen by the histidine and donation of a proton by the glutamic acid back to the C-1 oxygen leads to product formation.
During the second step of the pathway, ␣-D-galactose is phosphorylated to galactose-1-phosphate by the action of galactokinase. The three-dimensional structures of the galactokinases from L. lactis, Pyrococcus furiosus, and human have been shown to adopt a bilobal motif with the active site wedged between the N-and C-terminal domains (9 -12) . In the case of the human enzyme, the structure was solved in the presence of ␣-D-galactose and the non-hydrolyzable analog AMPPNP. 1 Examination of the active site geometry with these bound ligands suggests that two conserved residues, Arg-37 and Asp-186, may play key roles in the reaction mechanism (11) . The actual mode of catalysis, however, is still not completely defined for the galactokinases.
The third enzyme required for normal galactose metabolism is galactose-1-phosphate uridylyltransferase, which catalyzes the reversible transfer of a UMP moiety from UDPglucose to galactose 1-phosphate thus yielding glucose 1-phosphate and UDP-galactose. In the case of the uridylyltransferase, the reaction proceeds through a double displacement mechanism whereby a histidine residue is transiently modified (13, 14) . Detailed structural analyses of the dimeric protein from Escherichia coli have revealed that each subunit displays a "half-barrel" motif and that His-166 is the active site base (15, 16) .
For the pathway to be completed, UDP-galactose is converted back to UDP-glucose by UDP-galactose 4-epimerase. Over the years this enzyme has attracted significant research attention because of its interesting catalytic mechanism, including: 1) abstraction of the sugar 4Ј-hydroxyl hydrogen by an enzymatic base and hydride transfer from the C-4 of the sugar to the si-face of the nicotinamide ring of a tightly bound NAD ϩ cofactor, 2) rotation of the resulting 4Ј-ketopyranose intermediate in the active site to present the opposite face of the sugar to the reduced dinucleotide, and 3) transfer of the hydride from the nicotinamide ring of NADH back to the C-4 of the sugar and reprotonation of the C-4 oxygen. The structures of the enzymes from both E. coli and human have been * This work was supported by National Institutes of Health Grant DK47814 (to H. M. H.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The extensively studied (reviewed in Ref. 1) . From these investigations, it is now known that the epimerase belongs to the so-called short chain dehydrogenase/reductase superfamily (17) and that a conserved tyrosine residue functions as the active site base (18) .
The enzymes of the Leloir pathway are widespread in nature and have been isolated from both prokaryotes and eukaryotes. In most organisms, the four activities exist on separate polypeptide chains. Curiously, however, in both Saccharomyces cerevisiae and Kluyveromyces fragilis, the first and last enzymes of the pathway, namely the mutarotase and the epimerase, are contained on single polypeptide chains that associate to form homodimers (19, 20) . Indeed, enzymatic assays have clearly demonstrated the existence of both mutarotase and epimerase activities on the same protein (19, 20) .
In yeast, the epimerase/mutarotase protein is encoded by the GAL10 gene and thus for simplicity will hereafter be referred to as Gal10p. Recent sequence analyses have suggested that the N-terminal region of S. cerevisiae Gal10p, defined by the residues Met-1 to Thr-377, is homologous to the E. coli and human epimerases, whereas the C-terminal residues, Ile-378 to Ser-699, show sequence identity to the mutarotases from L. lactis and human (19, 20) .
Here we describe the cloning, over-expression in E. coli, protein purification, and x-ray crystallographic analysis of the S. cerevisiae Gal10p to 1.85-Å resolution. Strikingly, the molecule folds into two separate and distinct domains connected by a simple Type II turn. This investigation represents the first structural analysis of a dual function enzyme in the Leloir pathway.
EXPERIMENTAL PROCEDURES
Cloning of the GAL10 Gene-The yeast GAL10 gene was PCR-amplified from S. cerevisiae genomic DNA such that the forward and reverse primers added NheI and XhoI cloning sites, respectively. The gene was PCR-amplified with Platinum Pfx DNA polymerase (Invitrogen) according to the manufacturer's instructions and standard cycling conditions. The PCR product was purified with the QIAquick PCR purification kit (Qiagen) followed by A-tailing and subsequent ligation into the pGEM-T vector (Promega) for sequencing purposes. E. coli DH5␣ cells were transformed with the resulting vector. The GAL10 gene was sequenced with the ABI Prism TM Big Dye primer cycle sequencing kit (Applied Biosciences, Inc.), and one mutation was shown to be present, M518I. This was observed in three independent PCR reactions. The pGEM-T vector construct was then digested with NheI and XhoI, and the gene was separated from digestion by-products on a 1.0% agarose gel. The gene was excised from the gel, purified with the QIAquick gel extraction kit (Qiagen), and ligated into the expression vector pET-28b(ϩ) (Novagen) that was previously digested with NheI and XhoI. The pET28 plasmid was altered to provide a TEV protease recognition site thereby resulting in a construct that contains an additional 20 amino acid residues at the N terminus with the following sequence: MGSSHHHHHHSSENLYFQGH.
E. coli DH5␣ cells were transformed with the ligation mixture and plated onto LB/agar plates for selection with kanamycin. Individual colonies were selected and cultured overnight, and plasmid DNA was extracted with the QIAprep spin miniprep kit (Qiagen). Plasmids were tested for insertion of the GAL10 gene by digestion with NheI and XhoI.
Protein Expression and Purification-For protein expression, the pET28-GAL10 plasmid was used to transform E. coli HMS174(DE3) cells (Novagen). A starter culture from a single colony was grown overnight at 37°C in LB media supplemented with kanamycin. Subsequently, 10 ml were transferred to 1000 ml of supplemented TB media (50 mg/liter kanamycin and 1 g/liter galactose) in a 2-liter shaker flask and grown at 37°C until an optical density of ϳ0.8 was achieved at 600 nm. The culture was then transferred to a shaker at room temperature (ϳ20°C) and allowed to grow until an optical density of greater than 1.8 was obtained, at which point isopropyl 1-thio-␤-D-galactopyranoside was added to a final concentration of 0.05 mM. Cell growth was allowed to continue at room temperature for an additional 18 h.
The cells were harvested by centrifugation at 4000 ϫ g for 15 min and frozen in liquid nitrogen. Frozen cells (250 g) were thawed in 750 ml of lysis buffer consisting of 50 mM NaH 2 PO 4 , 100 mM galactose, 10 mM imidazole, and 300 mM NaCl (pH 8.0). The thawed cells were placed in an ice bath and disrupted by seven rounds of sonication (1-min duration each) separated by 5 min of cooling. Cellular debris was removed by centrifugation at 20,000 ϫ g for 25 min. The clarified supernatant was loaded onto a 25-ml column of nickel-nitrilotriacetic acid-agarose (Qiagen) that had been previously equilibrated with lysis buffer. The column was then washed with lysis buffer until the absorbance reading at 280 nm reached background level. The protein was eluted with a linear gradient of 10 -250 mM imidazole in lysis buffer. Protein-containing fractions were pooled based on purity as judged by SDS-PAGE and dialyzed against 10 mM Tris, 100 mM galactose, and 100 mM NaCl (pH 8.0). The dialyzed protein was further purified by anion exchange high pressure liquid chromatography using a 6-ml Resource-Q column. The protein was eluted at pH 8.0 (25 mM Tris plus 100 mM galactose) with a linear gradient from 50 -400 mM NaCl. Proteincontaining fractions were again pooled based on purity as judged by SDS-PAGE and dialyzed against 10 mM Tris, 100 mM galactose, and 200 mM NaCl (pH 8.0) and concentrated to 12.0 mg/ml based on an extinction coefficient of 0.95 cm/(mg⅐ml) as calculated with the pro-SCHEME 1
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gram Protean (DNASTAR, Inc., Madison, WI). A typical yield was ϳ125 mg of protein/250 g of cells.
Crystallization of Gal10p-A search for crystallization conditions was conducted at both room temperature and at 4°C via the hanging drop method of vapor diffusion utilizing an "in-house" designed sparse matrix screen composed of 144 conditions. The best crystals were observed growing at room temperature from pentaerythritol propoxylate ((5/4 PO/OH), typical molecular weight 426) at pH 7.5 and 10 mM UDP-glucose. Large single crystals were subsequently obtained from hanging drop experiments with precipitant solutions of 20 -25% pentaerythritol propoxylate buffered with 100 mM Hepes (pH 7.5) and enzyme concentrations of 12.0 mg/ml plus 10 mM UDPglucose. Single crystals grew to maximum dimensions of ϳ1.0 ϫ 0.5 ϫ 0.3 mm in 5-10 days. They belonged to the space group I222 with unit cell dimensions of a ϭ 120.9 Å, b ϭ 125.2 Å, and c ϭ 142.3 Å. The asymmetric unit contained one monomer.
Structural Analysis of Gal10p-An x-ray data set was collected to 1.85-Å resolution at 100 K with a Bruker AXS Platinum 135 chargecoupled device detector controlled with the Proteum software suite (PROTEUM, Bruker AXS Inc., Madison, WI). The x-ray source was CuK␣ radiation from a Rigaku RU200 x-ray generator equipped with montel optics and operated at 50 kV and 90 mA. The x-ray data were processed with SAINT (version V7.06A, Bruker AXS Inc.) and internally scaled with SADABS 2 version 2005/1, Bruker AXS Inc.). Crystals were frozen for x-ray data collection at 100 K by transferring them to a cryoprotect solution composed of 36% pentaerythritol propoxylate (5/4 PO/OH), 15 mM UDP-glucose, 125 mM D-galactose, 350 mM NaCl, 6% ethylene glycol, and 100 mM Hepes (pH 7.5). X-ray data collection statistics are presented in Table I .
The structure was solved by molecular replacement with the program EPMR. The epimerase domain was first located using the x-ray coordinates for human epimerase (Protein Data Bank accession number 1EK6) as a search model. One solution with a correlation coefficient of 31% and an R-factor of 54% was identified. This fragment was then held stationary, and a second molecular replacement search was conducted using coordinates for human mutarotase (Protein Data Bank accession number 1SO0) as a search model. The best solution had a correlation coefficient of 43% and an R-factor of 48%. Several cycles of least squares refinement with the software package TNT (21) followed by manual model building led to good overall improvement in the electron density corresponding to the epimerase domain but no improvement in the electron density corresponding to the mutarotase domain. At this point the protein loops in the region where the epimerase and mutarotase domains contact one another were removed, and the position for the mutarotase portion was reevaluated with EPMR. A new solution led to substantial improvement in the electron density for the mutarotase domain. Alternate cycles of manual model building and least squares refinement reduced the R-factor to 19.6% for all measured x-ray data to 1.85-Å resolution. Refinement statistics are presented in Table II .
RESULTS AND DISCUSSION
Quality of the X-ray Model-The overall quality of the model is excellent with only six residues lying well outside of the allowed regions of the Ramachandran plot. The electron density for these residues (Phe-193, Ala-366, Asn-432, Ser-460, Ser-653, and Tyr-669) is unambiguous, and indeed, the homol- The first residue for which electron density is observable is Ser-11. There are breaks in the polypeptide chain between Phe-233 and Arg-240 and Tyr-305 and Val-315. These breaks occur in the epimerase domain and are located near the UDP-glucose binding pocket. Electron density in this area is broken and impossible to interpret with any certainty but is indicative of multiple conformations. Additionally, the UDPglucose ligand appears disordered in the electron density map (Fig. 1a) , which is most likely because of low occupancy. Previous investigations of human UDP-galactose 4-epimerase have demonstrated that it is this region that adopts different conformations depending upon the presence or absence of UDP-glucose in the active site. In all other structural analyses conducted in this laboratory on either the human or E. coli forms of UDP-galactose 4-epimerase, this region has always been well ordered and the UDP-glucose density unambiguous. Following the break between Tyr-305 and Val-315, the polypeptide chain backbone for Gal10p extends continuously to Ser-699, which is the C terminus. Electron density corresponding to the galactose moiety is shown in Fig. 1b .
Overall Structure of the Gal10p Monomer-A ribbon representation of the Gal10p monomer, which has overall dimensions of ϳ91 ϫ 82 ϫ 69 Å, is displayed in Fig. 2a . The polypeptide chain can be envisioned as two separate domains separated by a short loop. There are three cis-prolines observed at positions 150, 472, and 596. Both Pro-150 and Pro-596 reside on the surface of the molecule, whereas Pro-472 is located in the interstitial region formed between the two domains. The cis conformation at position 150 also occurs in both human and E. coli epimerases (18, 22) .
The epimerase domain of Gal10p extends from the N terminus to Gln-356 and adopts the typical topology observed for members of the short chain dehydrogenase/reductase superfamily. Specifically, the N-terminal motif contains a modified Rossmann fold with a seven-stranded parallel ␤-sheet flanked 2 G. M. Sheldrick, unpublished data. by seven ␣-helices, whereas the C-terminal motif contains two ␤-strands and three major ␣-helical regions. The active site is wedged between the N-and C-terminal motifs. The mutarotase domain is formed by Glu-361 to Ser-699 and contains 21 ␤-strands. This type of ␤-sandwich architecture was first observed in domain 5 of ␤-galactosidase (23). The active site for the mutarotase domain is located in a quite shallow cleft. Strikingly, the epimerase and mutarotase active sites within the monomer are separated by over 50 Å. Two sodium ions were identified in the electron density map for Gal10p. These ions are located within the interstitial region formed by the epimerase and mutarotase domains as indicated in Fig. 2b . The first ion (B-factor of 51.5 Å 2 ) is coordinated by the side chains of Asn-351 and Gln-475, the carbonyl oxygen of Glu-350, and three water molecules in a distorted octahedral arrangement. The second ion (B-factor of 38.1 Å 2 ) is surrounded in an octahedral environment by the carbonyl oxygens of Leu-357 and Val-360, and four water molecules. Metal-ligand bond lengths range from 2.3 to 3.0 Å. These ions may play a role in stabilizing the single loop that connects the epimerase and mutarotase domains.
In addition to the loop connecting the two domains, the interface is also formed by Tyr-49 to Glu-67 (which constitutes the second helix and the third ␤-strand of the Rossmann fold), Glu-367 to Asp-372 (which is in random coil) and Phe-469 to Asp-480 (which lies in a ␤-strand). These regions are labeled A, B, and C, respectively, in Fig. 2a . The total buried surface area within the interfacial region is ϳ2200 Å 2 using a probe sphere of radius 1.4 Å (24). As shown in Fig. 2b , there is a patch of aromatic residues formed by Tyr-49 and Phe-65 of the epimerase domain and Tyr-371 of the mutarotase domain that participate in stacking interactions. There are also numerous hydrogen bonds that occur within the domain-domain interface including those formed between N 2 of Arg-54 and O of Ile-474, O ⑀1 of Glu-56 and N of Gly-471, and O ⑀1 of Glu-67 and O of Tyr-371. Gal10p has been reported to be a homodimer (19, 20) . Crystals employed in this investigation belonged to the space group I222. In this crystalline lattice the dimeric enzyme packed with its local 2-fold rotational axis coincident to a crystallographic dyad. Shown in Fig. 2c is a ribbon represen-FIG. 1 . Electron density corresponding to the bound ligands. Electron densities corresponding to the bound NAD ϩ and UDP-glucose or ␤-D-galactose ligands are displayed in a and b, respectively. The maps were calculated with coefficients of the form (F o Ϫ F c ), where F o was the native structure factor amplitude and F c was the calculated structure factor amplitude from the model lacking coordinates for the ligands. The maps were contoured at 2 . tation of the homodimer, which has overall dimensions of ϳ91 ϫ 135 ϫ 108 Å and an almost V-shaped appearance. The subunit-subunit interface is formed solely by a four-helix bundle contributed by the epimerase domains. This type of quaternary structural organization is virtually identical to that observed in both the E. coli and human epimerases The bound ligands are displayed in spacefilling representations. A close-up view of the interstitial region between the epimerase and mutarotase domains of the monomer is depicted in b. There are two sodium ions located in this region, both of which are octahedrally coordinated as indicated by the dashed lines. The Gal10p dimer is depicted in mono vision in c. The position of the crystallographic 2-fold rotational axis relating one subunit to another is indicated by the black arrow. (18, 22) . The total buried surface for the homodimer is 1800 Å 2 . The Epimerase Active Site-A close-up view of the active site for the epimerase domain is shown in Fig. 3a . Potential hydrogen bonding interactions between the protein and the NAD ϩ are indicated by the dashed lines. Since the UDP-glucose moiety was not well ordered, Fig. 3a only depicts the protein region surrounding the dinucleotide. The relative orientation of the UDPglucose with respect to the NAD ϩ ligand can be obtained from Fig.  1b . Note that the enzyme, as isolated and purified, contains tightly bound NAD(H).
There are seven ordered water molecules lying within 3.2 Å of the dinucleotide, all of which are also observed in human UDP-galactose 4-epimerase (18) . An intramolecular hydrogen bond (2.8 Å) occurs between the carboxamide nitrogen of the nicotinamide ring (which is in the syn conformation) and an ␣-phosphoryl oxygen. Both riboses of the dinucleotide adopt the C 2Ј -endo pucker. Twenty-five hydrogen bonding interactions occur between the NAD ϩ and the protein or solvent. This type of extensive hydrogen bonding network is typical for the UDP-galactose 4-epimerases that bind the dinucleotide cofactor irreversibly. Tyr-163 and Lys-167, located near the nicotinamide ribose, belong to the signature sequence YXXXK that is characteristic for members of the short chain dehydrogenase/reductase superfamily. Indeed, Tyr-163 or its structural equivalent in other enzymes serves as the catalytic base required for the epimerization reaction (18) .
The Mutarotase Active Site-Shown in Fig. 3b is a stereo representation of the active site surrounding the bound galactose. The electron density reveals that only the ␤-anomer is present. This is in keeping with that observed for human Glu-665 most likely functions as the active site base and that His-537 serves as the active site acid.
Comparison of Gal10p with Human UDP-Galactose 4-Epimerase and Human Mutarotase-The structural correspondence between the epimerase domain of Gal10p and human epimerase is extensive with a root mean square deviation of 0.8 Å for 316 structurally equivalent ␣-carbons. The amino acid sequence identity between them is ϳ54%. A superposition of the ␣-carbon traces for these two enzymes is given in Fig. 4a . The most striking difference is a six-residue deletion in Gal10p beginning at Thr-48. In human epimerase the sequence of this loop (labeled A in Fig. 4c) is Arg-Gly-GlyGly-Ser-Leu and cannot be accommodated in Gal10p because of the close proximity of the attached mutarotase domain. In addition to this deletion, there are two 4-residue insertions in Gal10p, relative to the human epimerase, beginning at Thr-143 and Tyr-268, respectively.
The amino acid sequence identity between the Gal10p mutarotase domain and human mutarotase is 35%, and the two models correspond with a root mean square deviation of 1.2 Å for 285 structurally equivalent ␣-carbons. A comparison of the ␣-carbon traces for these proteins is depicted in Fig. 4b . The two proteins differ notably in a few places. Perhaps the most relevant is the change in conformation beginning at Ala-366 of Gal10p. The loop in Gal10p connecting the first and second ␤-strands of the mutarotase domain is two residues shorter but more importantly adopts a significantly different conformation (labeled B in Fig. 4c ). This loop contains Tyr-371 that forms part of the previously described aromatic patch of the interstitial region.
Conclusions-In most organisms the four enzymatic activities required for normal galactose metabolism exist as separate polypeptide chains. Yet in all yeast species for which complete genomes are known, the first and last enzymes of the pathway are contained within a single polypeptide chain. In the case of Gal10p from S. cerevisiae, the epimerase and mutarotase domains are completely separate structural units connected by a Type II turn (Leu-357 to Val-360). If and how the two active sites of Gal10p communicate with one another is currently not understood. Experiments designed to address this issue are presently under way. 3 The selective advantage of having the first and last enzymes of a metabolic pathway contained within a single polypeptide chain is not immediately apparent. Given the unusual shape of the Gal10p dimer (Fig. 2c) , it is tempting to speculate, however, that some type of substrate channeling occurs in vivo. At present there is limited evidence in this regard. One recent investigation, however, has demonstrated that a green fluorescent protein-tagged fusion protein of galactose-1-phosphate uridylyltransferase from S. cerevisiae localizes to discrete spots in the cytoplasm of the majority of the cells tested (25) . Strikingly, in those yeast cells lacking galactokinase, Gal10p, or both, this localization did not occur. Whether or not substrate channeling is occurring in the enzymes of the Leloir pathway is an intriguing question. The present structure is certainly provocative. Understanding the cellular organization of the Leloir pathway enzymes in vivo is clearly the next challenge in fully characterizing this important and fascinating metabolic pathway.
